OLMA — Olema Pharmaceuticals, Inc. stock price, charts and financials

QT52Olema Pharmaceuticals, Inc.

Olema Pharmaceuticals, Inc. (NASDAQ: OLMA) is a Healthcare company in the Biotechnology industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.

Latest market price
11.76
+0.48+4.26%
OverviewShort InterestFilings
OLMAQT52Olema Pharmaceuticals, Inc.·NASDAQ
11.76+4.26%

Latest SEC Filings

Form category
Filing Date ▾FormDescriptionFilingDocument
Jul 29, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Jul 27, 20264Statement of changes in beneficial ownership
Jun 23, 20264Statement of changes in beneficial ownership
Jun 23, 20264Statement of changes in beneficial ownership
Jun 23, 20264Statement of changes in beneficial ownership
Jun 23, 20264Statement of changes in beneficial ownership
Jun 23, 20264Statement of changes in beneficial ownership
Jun 23, 20264Statement of changes in beneficial ownership
Jun 23, 20264Statement of changes in beneficial ownership
Jun 23, 20264Statement of changes in beneficial ownership
Jun 23, 20264Statement of changes in beneficial ownership
Jun 23, 20268-KCurrent report
Jun 23, 20264Statement of changes in beneficial ownership
Jun 23, 20264Statement of changes in beneficial ownership
May 26, 20268-KCurrent report
May 21, 20268-KCurrent report
May 15, 2026SC 13G/ABeneficial ownership statement (passive, amended)
May 15, 2026SC 13G/ABeneficial ownership statement (passive, amended)
May 12, 202610-QQuarterly report
May 12, 20268-KCurrent report
May 01, 20268-KCurrent report
Apr 29, 20268-KCurrent report
Apr 29, 2026DEFA14AAdditional proxy soliciting materials
Apr 29, 20264Statement of changes in beneficial ownership
Apr 29, 2026DEF 14ADefinitive proxy statement
#1 / 25 of 354
Page
▼
/ 15